Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia

Clinical trial NCT02293993 · COMPLETED

Trial details

NCT number: NCT02293993
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2015-01-07
Primary completion: 2017-06-14
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.